DK0655916T3 - Middel til transdermal administration indeholdende 3-ketodesogestrel - Google Patents

Middel til transdermal administration indeholdende 3-ketodesogestrel

Info

Publication number
DK0655916T3
DK0655916T3 DK93919108T DK93919108T DK0655916T3 DK 0655916 T3 DK0655916 T3 DK 0655916T3 DK 93919108 T DK93919108 T DK 93919108T DK 93919108 T DK93919108 T DK 93919108T DK 0655916 T3 DK0655916 T3 DK 0655916T3
Authority
DK
Denmark
Prior art keywords
agent
ketodesogestrel
transdermal administration
administration containing
desogestrel
Prior art date
Application number
DK93919108T
Other languages
English (en)
Inventor
Ralph Lipp
Jutta Riedl
Nther Clemens G
Ulrich Taeuber
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0655916T3 publication Critical patent/DK0655916T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
DK93919108T 1992-08-21 1993-08-19 Middel til transdermal administration indeholdende 3-ketodesogestrel DK0655916T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4227989A DE4227989A1 (de) 1992-08-21 1992-08-21 Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
PCT/EP1993/002224 WO1994004157A1 (de) 1992-08-21 1993-08-19 Mittel zur transdermalen applikation enthaltend 3-keto-desogestrel

Publications (1)

Publication Number Publication Date
DK0655916T3 true DK0655916T3 (da) 1998-09-23

Family

ID=6466236

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93919108T DK0655916T3 (da) 1992-08-21 1993-08-19 Middel til transdermal administration indeholdende 3-ketodesogestrel

Country Status (13)

Country Link
EP (1) EP0655916B1 (da)
JP (1) JPH08500584A (da)
AT (1) ATE162945T1 (da)
AU (1) AU687013B2 (da)
CA (1) CA2141690A1 (da)
DE (2) DE4227989A1 (da)
DK (1) DK0655916T3 (da)
ES (1) ES2115071T3 (da)
FI (1) FI950774A (da)
GR (1) GR3026627T3 (da)
HU (1) HUT69406A (da)
NO (1) NO307325B1 (da)
WO (1) WO1994004157A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9408457A (pt) * 1993-12-27 1997-08-05 Akzo Nobel Nv Preparação farmacêutica percutânia
EP0741572A1 (de) * 1994-01-27 1996-11-13 Schering Aktiengesellschaft MITTEL ZUR TRANSDERMALEN APPLIKATION ENTHALTEND 14$g(a),17$g(a)-ETHANOESTRA-1,3,5(10)-TRIEN-3,17$g(b)-DIOL
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
AU703593B2 (en) * 1995-06-07 1999-03-25 Ortho-Mcneil Pharmaceutical, Inc. Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
EP0848620A1 (de) * 1995-07-17 1998-06-24 Schering Aktiengesellschaft Mittel zur transdermalen applikation enthaltend ester des 3-ketodegestrel
FR2749514B1 (fr) * 1996-06-11 1998-08-07 Hoechst Marion Roussel Systemes transdermiques renfermant 2 principes actifs dans des compartiments separes, leur procede de preparation et leur application comme medicament
KR100496109B1 (ko) * 1996-06-11 2005-09-09 아벤티스 파마 소시에떼아노님 개별격실에2종의활성성분을함유하는경피시스템,그의제조방법및의약으로서의그의용도
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
US6987101B1 (en) * 1996-12-20 2006-01-17 Schering Aktiengesellschaft Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
EP1041982B1 (en) 1997-12-22 2011-10-19 Bayer HealthCare LLC INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
RU2225714C2 (ru) * 1998-03-09 2004-03-20 Акцо Нобель Н.В. Новый набор противозачаточных средств
WO2000009136A1 (en) * 1998-08-11 2000-02-24 Akzo Nobel N.V. Progestogen-only contraceptive kit providing good cycle control
US20020065296A1 (en) 1999-01-13 2002-05-30 Bayer Corporation Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
EP2298311B1 (en) 1999-01-13 2012-05-09 Bayer HealthCare LLC w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
EP2305267A3 (en) 1999-08-31 2011-08-17 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
US6787531B1 (en) 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
ME00329B (me) 1999-08-31 2011-05-10 Bayer Schering Pharma Ag Farmaceutska kombinacija etiilestradiola i drospirenona za primjenu kao kontraceptiynog sredstva
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
PT1450799E (pt) 2001-12-03 2007-01-31 Bayer Pharmaceuticals Corp Compostos de arilureia em combinação com outros agentes citostáticos ou citotóxicos para tratamento de cancros humanos
MXPA04007832A (es) 2002-02-11 2005-09-08 Bayer Pharmaceuticals Corp Aril-ureas con actividad inhibitoria de angiogenesis.
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
TW200403065A (en) 2002-05-30 2004-03-01 Akzo Nobel Nv New etonogestrel esters
AU2003296810A1 (en) * 2002-12-10 2004-07-09 Besins International Belgique Pharmaceutical composition for transdermal or transmucous administration comprising a progestin or an estrogen, method for preparing same and uses thereof
FR2848112B1 (fr) * 2002-12-10 2007-02-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant au moins un progestatif et/ou au moins un oestrogene, son procede de preparation et ses utilisations
FR2851470B1 (fr) 2003-02-20 2007-11-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse
WO2007011764A2 (en) * 2005-07-15 2007-01-25 Bayer Schering Pharma Aktiengesellschaft Drospirenone containing transdermal drug delivery devices and methods of delivery thereof
AU2006299833B2 (en) 2005-10-12 2012-04-12 Besins Healthcare Luxembourg Sarl Improved testosterone gel and method of use
WO2007053574A2 (en) 2005-10-31 2007-05-10 Bayer Pharmaceuticals Corporation Combinations comprising sorafenib and interferon for the treatment of cancer
EP2094268A2 (en) 2006-05-26 2009-09-02 Bayer HealthCare, LLC Drug combinations with substituted diaryl ureas for the treatment of cancer
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
TW200840595A (en) * 2006-12-12 2008-10-16 Organon Nv Oral contraceptive spray
US8148532B2 (en) 2007-03-14 2012-04-03 Guoqing Paul Chen Spiro substituted compounds as angiogenesis inhibitors
BRPI0814697B8 (pt) 2007-07-10 2021-05-25 Agile Therapeutics Inc dispositivo de liberação de fármacos
US8211911B2 (en) 2008-08-19 2012-07-03 Guoqing Paul Chen Compounds as kinase inhibitors
US10080760B2 (en) 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
CA2805874A1 (en) 2010-07-19 2012-01-26 Bayer Healthcare Llc Drug combinations with fluoro-substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
CN1021196C (zh) * 1986-12-29 1993-06-16 新泽西州州立大学(鲁杰斯) 透皮雌激素/孕激素药剂单元、系统及方法
IE62665B1 (en) * 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive

Also Published As

Publication number Publication date
CA2141690A1 (en) 1994-03-03
HU9500510D0 (en) 1995-04-28
GR3026627T3 (en) 1998-07-31
FI950774A0 (fi) 1995-02-20
EP0655916A1 (de) 1995-06-07
JPH08500584A (ja) 1996-01-23
WO1994004157A1 (de) 1994-03-03
AU687013B2 (en) 1998-02-19
HUT69406A (en) 1995-09-28
AU4950493A (en) 1994-03-15
DE4227989A1 (de) 1994-06-09
NO950626D0 (no) 1995-02-20
FI950774A (fi) 1995-02-20
ATE162945T1 (de) 1998-02-15
DE59308124D1 (de) 1998-03-12
NO950626L (no) 1995-02-20
NO307325B1 (no) 2000-03-20
EP0655916B1 (de) 1998-02-04
ES2115071T3 (es) 1998-06-16

Similar Documents

Publication Publication Date Title
DK0655916T3 (da) Middel til transdermal administration indeholdende 3-ketodesogestrel
DK138590D0 (da) Middel til transdermal applikation indeholdende gestoden
DK588487A (da) Forbedrede metalholdige farmaceutiske midler
AU2332188A (en) Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors
ES2123547T3 (es) Formulaciones, metodos y dispositivos contraceptivos transdermicos.
MXPA97002401A (es) Agente antiinflamatorio para uso externo.
DE68912237T2 (de) Dampfsensitive Zusammensetzung sowie diese enthaltende sterilisierungsanzeigende Zusammensetzung.
ES2137372T3 (es) Solucion antifungica para las uñas.
CA2170255A1 (en) Pharmaceutical Composition for Immunoenhancement Therapy
DE3854383T2 (de) Mesomorphische Verbindung, Flüssigkristallzusammensetzung und Flüssigkristallvorrichtung.
TR199802351T2 (xx) Topikal kullanım için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bileşimi.
ES458559A1 (es) Procedimiento de preparacion de una nueva composicion cosme-tica para la piel.
NO963433L (no) Middel for transdermal applisering inneholdende desogestrel
NO841645L (no) Innretning, saerlig anvendbar som differensialbrems og differensialsperre.
DE68909555T2 (de) Pyridylketoximether-Verbindung und diese enthaltende pharmazeutische Zusammensetzung.
ES2152315T3 (es) Xamoneline tartrato.
GB2203041B (en) Plaster having thereon an antiinflammatory and analgesic composition for external application.
ES2054099T3 (es) Composicion estabilizada de interleucina-1-g(b).
NO963128D0 (no) Middel for transdermal applikasjon inneholdende 14, 17-etanoöstra-1,3,5(10)-trien-3, 17-diol
DE59712215D1 (de) Transdermales therapeutisches system mit einer östriol enthaltenden bisphosphatekombination
JPS5287155A (en) Steroid derivatives and pharmaceutical agent having cortisone action
AU2149977A (en) Injectable male sterilant for selectively controlling the function ofthe testes